|
|
 |
|
Viewing report
|
|
|
|
Pfizer Inc. - SWOT Analysis
MarketLine, July 2011, Pages: 36
Pfizer Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Pfizer Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Pfizer is the world’s largest biopharmaceutical company. Its portfolio includes human and animal biologic, small molecule medicines, vaccines, nutritional and consumer products. The company operates in more than 150 countries. It is headquartered in New York City, New York and employed 110,600 people as of December 31, 2009. Pfizer completed the acquisition of King Pharmaceuticals, a US-based specialty pharmaceutical company, for $3.6 billion in February 2011. The company recorded revenues of $67,809 million during the financial year (FY) ended December 2010, an increase of 35.6% over FY2009. The operating profit of the company was $9,422 million during FY2010, a decrease of 13% over FY2009. The net profit was $8,257 million in FY2010, a decrease of 4.4% over FY2009.
Scope of the Report
- Provides all the crucial information on Pfizer Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Pfizer Inc.
-Data is supplemented with details on Pfizer Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Pfizer Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
